Homeobox B9 Promotes Colon Cancer Progression by Targeting SRSF3

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2023 May 31

PMID 37258980

Authors

Lebin Yuan

Fei Cheng

Zhao Wu

Xiaodong Li

Wei Shen

Affiliations

Soon will be listed here.

Abstract

Background: Homeobox B9 (HOXB9) is one of the HOX family of transcription factors that are essential for cancer development and embryonic growth. However, the clinical importance and biological involvement of HOXB9 in colon cancer (CC) are not adequately understood.

Aims: To investigate whether HOXB9 participates in the proliferation, invasion, and migration of CC.

Methods: This study investigated the function and clinical significance of HOXB9 mRNA and protein expression in CC. Furthermore, overexpression and knockdown experiments of HOXB9 were developed to explore their effects on CC cell transwell and proliferation. Moreover, a molecular mechanism of HOXB9 regulate serine/arginine-rich splicing factor 3 (SRSF3) was explored.

Results: HOXB9 expression was higher in CC cells and tissues at both the mRNA and protein levels. Poor survival in CC patients was significantly connected with high HOXB9 expression, which was also strongly associated with the TNM stage and lymph node metastases. Furthermore, in vitro CC cell proliferation, transwell were markedly aided by HOXB9 overexpression. Contrarily, HOXB9 knockdown had the reverse result and inhibited the formation of xenograft tumors in naked mice. Gene set enrichment analysis (GSEA) revealed a correlation between high HOXB9 expression and spliceosomes. JASPAR and GEPIA2.0, in addition to CHIP and dual-luciferase reporting assays, confirmed that HOXB9 targets the promoter of SRSF3 to enhance its expression. We also found that SRSF3 knockdown eliminated HOXB9 from cell proliferation and transwell.

Conclusion: We characterized the function and mechanism of HOXB9 in regulating colon cancer growth, suggesting a novel molecular approach for colon cancer-targeted therapy.

Citing Articles

Homeobox B9 promotes the invasion and metastasis of hepatocellular carcinoma cells via the EZH2-MIR203A-SNAI2 axis.

Zhang D, Qiu Y, Zhang W, Du D, Liu Y, Liu L J Transl Med. 2024; 22(1):918.

PMID: 39390614 PMC: 11465790. DOI: 10.1186/s12967-024-05690-x.

SNX16 is required for hepatocellular carcinoma survival via modulating the EGFR-AKT signaling pathway.

Yuan L, Meng Y, Xiang J Sci Rep. 2024; 14(1):13093.

PMID: 38849490 PMC: 11161632. DOI: 10.1038/s41598-024-64015-6.

References

Markowitz S, Bertagnolli M . Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med. 2009; 361(25):2449-60. PMC: 2843693. DOI: 10.1056/NEJMra0804588. View

Dekker E, Tanis P, Vleugels J, Kasi P, Wallace M . Colorectal cancer. Lancet. 2019; 394(10207):1467-1480. DOI: 10.1016/S0140-6736(19)32319-0. View

Tauriello D, Palomo-Ponce S, Stork D, Berenguer-Llergo A, Badia-Ramentol J, Iglesias M . TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis. Nature. 2018; 554(7693):538-543. DOI: 10.1038/nature25492. View

Araghi M, Arnold M, Rutherford M, Guren M, Cabasag C, Bardot A . Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut. 2020; 70(1):114-126. DOI: 10.1136/gutjnl-2020-320625. View

Garcia-Fernandez J . The genesis and evolution of homeobox gene clusters. Nat Rev Genet. 2005; 6(12):881-92. DOI: 10.1038/nrg1723. View

Grier D, Thompson A, Kwasniewska A, McGonigle G, Halliday H, Lappin T . The pathophysiology of HOX genes and their role in cancer. J Pathol. 2005; 205(2):154-71. DOI: 10.1002/path.1710. View

Wang T, Guo H, Li Q, Wu W, Yu M, Zhang L . The AMPK-HOXB9-KRAS axis regulates lung adenocarcinoma growth in response to cellular energy alterations. Cell Rep. 2022; 40(8):111210. DOI: 10.1016/j.celrep.2022.111210. View

Hayashida T, Takahashi F, Chiba N, Brachtel E, Takahashi M, Godin-Heymann N . HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis. Proc Natl Acad Sci U S A. 2010; 107(3):1100-5. PMC: 2824265. DOI: 10.1073/pnas.0912710107. View

Yao Y, Liu C, Wang B, Guan X, Fang L, Zhan F . HOXB9 blocks cell cycle progression to inhibit pancreatic cancer cell proliferation through the DNMT1/RBL2/c-Myc axis. Cancer Lett. 2022; 533:215595. DOI: 10.1016/j.canlet.2022.215595. View

10.

Zhang L, Wu Q, He C, Liang D, Yi Q, Shi J . HOXB9 inhibits proliferation in gastric carcinoma cells via suppression of phosphorylated-Akt and NF-κB-dependent Snail expression. Dig Liver Dis. 2018; 51(1):157-165. DOI: 10.1016/j.dld.2018.08.018. View

11.

Nguyen D, Chiang A, Zhang X, Kim J, Kris M, Ladanyi M . WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell. 2009; 138(1):51-62. PMC: 2742946. DOI: 10.1016/j.cell.2009.04.030. View

12.

Wan J, Xu W, Zhan J, Ma J, Li X, Xie Y . PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6. Nucleic Acids Res. 2016; 44(22):10662-10675. PMC: 5159546. DOI: 10.1093/nar/gkw808. View

13.

Song J, Wang T, Xu W, Wang P, Wan J, Wang Y . HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progression. Cancer Lett. 2018; 426:63-72. DOI: 10.1016/j.canlet.2018.04.002. View

14.

Wan J, Liu H, Feng Q, Liu J, Ming L . HOXB9 promotes endometrial cancer progression by targeting E2F3. Cell Death Dis. 2018; 9(5):509. PMC: 5938704. DOI: 10.1038/s41419-018-0556-3. View

15.

Chiba N, Comaills V, Shiotani B, Takahashi F, Shimada T, Tajima K . Homeobox B9 induces epithelial-to-mesenchymal transition-associated radioresistance by accelerating DNA damage responses. Proc Natl Acad Sci U S A. 2011; 109(8):2760-5. PMC: 3286905. DOI: 10.1073/pnas.1018867108. View

16.

Huang K, Yuan R, Wang K, Hu J, Huang Z, Yan C . Overexpression of HOXB9 promotes metastasis and indicates poor prognosis in colon cancer. Chin J Cancer Res. 2014; 26(1):72-80. PMC: 3937747. DOI: 10.3978/j.issn.1000-9604.2014.01.11. View

17.

Mure F, Corbin A, Benbahouche N, Bertrand E, Manet E, Gruffat H . The splicing factor SRSF3 is functionally connected to the nuclear RNA exosome for intronless mRNA decay. Sci Rep. 2018; 8(1):12901. PMC: 6110769. DOI: 10.1038/s41598-018-31078-1. View

18.

Jumaa H, Nielsen P . The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation. EMBO J. 1997; 16(16):5077-85. PMC: 1170142. DOI: 10.1093/emboj/16.16.5077. View

19.

Zheng X, Peng Q, Wang L, Zhang X, Huang L, Wang J . Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer. Int J Biol Sci. 2020; 16(13):2442-2453. PMC: 7378643. DOI: 10.7150/ijbs.46751. View

20.

Long J, Caceres J . The SR protein family of splicing factors: master regulators of gene expression. Biochem J. 2008; 417(1):15-27. DOI: 10.1042/BJ20081501. View